EUVIMEDEUVIMED entdecken
Crossref

Resveratrol Nanoparticle Complex: Potential Therapeutic Applications in Myocardial Ischemia Reperfusion Injury

Hong Zhou, Yungang Shan, Fei Tong, Yi Zhang, Jie Tang, Ruilin Shen, Deqing Chen

Journal of Biomedical Nanotechnology · 01.03.2020 · 16 (3) · 382-389

DOI: 10.1166/jbn.2020.2900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Nanotechnology, erschienen am 01.03.2020. Verfasst von Hong Zhou und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resveratrol (RES) is a natural non-flavonoid polyphenol with cardioprotective activities, antioxidant, antiplatelet, and antiinflammatory. However, its low aqueous solubility, chemical stability, and oral bioavailability, as well as a short circulation half-life greatly limit its clinical applications. To overcome these limitations of RES, we synthesized a methoxy poly(ethylene glycol)- b -oligomerization(D, L-Leucine) (mPEG- b -O(D, L-Leu)) nanoparticle (NP) as the carrier of RES and evaluated the myocardial-protective effectiveness of this RES/NP complex in rat myocardial ischemia-reperfusion injury models. We gauged the characterization of the NP through proton nuclear magnetic resonance spectroscopy, gel permeation chromatography, transmission electron microscope, and Fourier transform infrared spectroscopy and then loaded RES on the nanocarrier by hydrophobic interactions under physiological pH to extend the release time of RES and prolong its circulation half-life. Subsequently, we used rat cardiomyocytes (H9C2 cells) and rat MI/RI model to investigate the relationship between drug composition and myocardial preservation properties. It was found that RES was encapsulated quickly and efficiently, and displayed an effectual loading-capacity and in vitro sustained-release. Anti-MI/RI effect of the RES/NP complex was found satisfactory in rat models in vivo using free RES as the control. This study suggested that NP may prove to be a potent nanocarrier to augment the pharmacotherapy of RES against MI/RI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryNanoparticlesAnimalsDrug CarriersMyocardiumPolyethylene GlycolsRatsResveratrol

Substanzen

Drug CarriersPolyethylene GlycolsResveratrol

Zitieren

APA

Zhou, H., Shan, Y., Tong, F., Zhang, Y., Tang, J., Shen, R., & Chen, D. (2020). Resveratrol Nanoparticle Complex: Potential Therapeutic Applications in Myocardial Ischemia Reperfusion Injury. Journal of Biomedical Nanotechnology, 16(3), 382-389. https://doi.org/10.1166/jbn.2020.2900

Vancouver

Zhou H, Shan Y, Tong F, Zhang Y, Tang J, Shen R, et al. Resveratrol Nanoparticle Complex: Potential Therapeutic Applications in Myocardial Ischemia Reperfusion Injury. Journal of Biomedical Nanotechnology. 2020;16(3):382-389. doi:10.1166/jbn.2020.2900

BibTeX
@article{Zhou2020,
  author = {Zhou, Hong and Shan, Yungang and Tong, Fei and Zhang, Yi and Tang, Jie and Shen, Ruilin and Chen, Deqing},
  title = {Resveratrol Nanoparticle Complex: Potential Therapeutic Applications in Myocardial Ischemia Reperfusion Injury},
  journal = {Journal of Biomedical Nanotechnology},
  year = {2020},
  volume = {16},
  number = {3},
  pages = {382--389},
  doi = {10.1166/jbn.2020.2900}
}
Kostenlos starten →